Skip to Main Content

Paper Details

MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.
Sci Rep
0
2023
-, AR, LNCaP cells, MED19, MED19 cells, MED19 isoform, MED19 isoforms, MED19-overexpressing LNCaP cells, alternative MED19 cells, androgen, androgen receptor, cancers, canonical MED19 cells, full-length "canonical", genes, mediator complex, metastatic prostate cancer, prostate adenocarcinomas, prostate cancer, prostate cancers, triggered genes
Author NameAffiliation
David Feny??Institute for Systems Genetics, New York University Grossman School of Medicine
David Feny??New York University Grossman School of Medicine
David Feny??Institute for Systems Genetics, New York University Grossman School of Medicine
David Feny??New York University Grossman School of Medicine
  • 1 - 4

Datasets

Release 1.2